EVE Signs Telehealth Services Agreement with hubMed
Filed with ASX · · 3 pages · English
Summary by 6ix AI
EVE Health Group Limited has signed a telehealth services agreement with hubMed to enhance patient support for its products in women's and men's health. The agreement establishes a nationwide Patient Support Program aimed at improving the safety and continuity of care for patients prescribed EVE's therapies. This program will provide accessible telehealth consultations delivered by independent clinicians, reinforcing patient adherence and communication with healthcare providers. The partnership is expected to strengthen EVE's ability to support patients dealing with conditions like dysmenorrhoea and erectile dysfunction.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
EVE Health Group Limited on 6ix
In the deck
Earlier from EVE Health
- Medical Science Liaison Appointed
- EVE Raises $1.1m to Accelerate Launches of Dyspro and Libbo
- Dyspro Prescribed to First Patients
- Eve Commences Distribution of Dyspro
- Appointment of Dr Fiona Cousins to Scientific Advisory Board
Later from EVE Health
- EVE Signs Telehealth Services Agreement with hubMed -Revised
- EVE Completes Initial Production of Libbo
- Quarterly Activities/Appendix 4C Cash Flow Report
- Launch of Libbo and Activation of Men's Health Platform
- Appendix 4D and Half Year Report
Follow EVE Health into a list and get an email when it puts out news.
Follow EVE Health